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Abstract 
INTRODUCTION: Anxiety disorders can be comorbid with schizophrenia. There was 38.3% of subjects with 
schizophrenia spectrum disorders suffer from at least one anxiety disorder. In the general population, it was found 
that higher levels of anxiety were experienced by women than men.  
AIM: To measure the difference between Hospital Anxiety and Depression Scale-Anxiety (HADS-A) scores in 
Batak male and female with schizophrenia.  
MATERIAL AND METHODS: This preliminary study was a comparative analytical study with a cross-sectional 
approach involving twenty participants, divided into two groups, Batak male and female in the stabilisation phase 
who was outpatient in Prof. Dr M. Ildrem Mental Hospital Medan. Patient with schizophrenia was filled 
questionnaire of HADS-A to measure score of anxiety.  
RESULTS: There was no statistically significant difference of HADS-A score from Batak male and female with 
schizophrenia with p-value 0.129.  
CONCLUSION: From this preliminary study we found that there was no statistically significant of HADS-A scores 
in Batak male and female with schizophrenia maybe because of stabilisation phase whereas patients have got 
treatment, so the scores of anxieties have decreased. 
 
 
 
 
 
 
Introduction 
 
Schizophrenia is a chronic disease which is 
the most serious mental disorder. The risk of suffering 
for life reaches 1% of the population in the world [1]. 
The affective disorder often becomes comorbid with a 
schizophrenic patient [2]. 
A study identifies the importance of increasing 
emotional pressure, especially anxiety, as an 
important component in the presence of delusion. 
Anxiety and depression are important factors in the 
manifestation and persistence of thought disorder [2]. 
Several studies have found an increase in the level of 
symptoms and syndrome of anxiety in people with 
schizophrenia. The results show that 38.3% of 
subjects with schizophrenia spectrum disorders suffer 
from at least one anxiety disorder [3]. 
A study conducted by Naidu et al., in South 
Africa were measured depression and anxiety using a 
Structured Clinical Interview for Positive and Negative 
Syndrome Scale (SCI-PANSS), the Calgary 
Depression Scale for Schizophrenia (CDSS) , The 
Hamilton Anxiety Rating Scale (HAM-A) and the 
Staden Schizophrenia Anxiety Rating Scale (S-SARS) 
in acute phase indicated that the higher of SCI-
PANSS score, CDSS, HAM-A and S-SARS scores 
can be predicted to be statistically significantly higher 
[4]. 
According to the Anxiety Disorders 
Association of America (ADAA), there is large 
evidence from a survey conducted in the general 
population which confirms that each anxiety disorder 
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in DSM IV is more common in women than men. 
Women are at high risk of experiencing anxiety 
disorders, where developmental, social and 
reproductive factors are believed to contribute to this 
vulnerability [5]. 
However, the results of different studies were 
found by Allan et al., in the UK to investigate the 
psychometric properties of HADS and the internal 
reliability of HADS which found that the sex of 
schizophrenic patients did not have a statistically 
significant effect on anxiety scores [2]. 
Based on this background and through 
literature review, there have been no studies 
examining anxiety in schizophrenic patients based on 
gender in the stabilisation phase of schizophrenia 
treatment, especially in North Sumatra and even in 
Indonesia. The research will also be directed at Batak 
tribe because the Batak tribe is one of the largest 
tribes in North Sumatra with high expressed emotion 
in their culture and ethnicity also can affect anxiety.  
From this background, the researcher wanted 
to see whether there is a difference between Hospital 
Anxiety and Depression Scale – Anxiety (HADS-A) 
scores in Batak male and female with schizophrenia in 
stabilisation phase at Prof. dr. M. Ildrem Mental 
Hospital, Medan.  
 
 
Material and Methods 
 
This preliminary study was conducted in Prof. 
dr. M. Ildrem Mental Hospital, Medan, from January to 
April 2018. The patients who came to the outpatient 
clinic were selected based on inclusion criteria. 
Inclusion criteria included: male and female patients 
with a diagnosis of schizophrenia according to 
PPDGJ-III, 20-35 years of age, stabilisation phase of 
treatment, Bataknese, current treatment with 
antipsychotic Risperidone 2mg twice daily, 
unemployment, never married or divorced or 
widowed, not currently pregnancy and ability to give 
informed consent.  
Patients were excluded if they have a family 
history of mental-emotional disorder, substance or 
alcohol use or dependence disorder (excluding 
nicotine and caffeine) and suffered from medical 
illness.  
Total twenty patients, Batak male and female, 
have been selected and completed a questionnaire, 
Hospital Anxiety and Depression Scale-Anxiety 
(HADS-A) to measure the score of anxiety. Hospital 
Anxiety and Depression Scale (HADS), was 
constructed in 1983 by Zigmond and Snaith [6]. It 
consists of two separate subscales: anxiety (HADS-A) 
and depression (HADS-D) scale. Each of the 
subscales contains 7 statements about the current 
condition of the test person, and the results are 
counted and interpreted separately. Each item 
contains four points (0–3) with scores ranging from 0 
to 21 for anxiety and 0 to 21 for depression. The 
anxiety scale measures the general anxiety, 
unfocused on a particular situation.
7
 In Indonesia, 
Rudy M et al. had been tested for reliability test in 
Indonesian version. The results of the interrater 
agreement for HADS-A were 0.706. The result of the 
interrater agreement for HADS-D is 0.681. Where the 
value of 0.61-0.80 means that the Cohen Kappa 
agreement is good [8]. 
 
Statistical Analysis 
This study is a comparative analytical study of 
two unpaired groups with a cross-sectional approach 
that is by describing and analysing a situation at a 
certain time using Hospital Anxiety and Depression 
Scale-Anxiety (HADS-A) instrument. 
 
 
Results 
 
 The results of the demographic characteristics 
of the research study are shown in Table 1. The 
differences are statistically non-significant. 
Table 1: Demographic Characteristic of Research Study 
 Batak Male with Schizophrenia 
(mean ± s.d) 
Batak Female with 
Schizophrenia (mean ± s.d) 
p 
Age (year) 
PANSS Score 
31.80 ± 3.458 
42.90 ± 6.773 
31.20 ± 3.011 
42.50 ± 7.028 
0.684 
0.898 
 
The differences in HADS-A score of Batak 
male and female with schizophrenia are shown in 
Table 2. The difference is statistically non-significant. 
Table 2: The difference of HADS-A Score of Batak Male and 
Female with Schizophrenia 
 Batak Male with Schizophrenia 
(mean ± s.d) 
Batak Female with 
Schizophrenia (mean ± s.d) 
p 
HADS-A Score 5.30 ± 2.45 3.60 ± 2.32 0.129 
 
 
 
Discussion 
 
This study is still ongoing, and the results of 
the preliminary study are not yet represented the 
population of the subject. The subjects that we choose 
are in the stabilisation phase of schizophrenia 
treatment. They have taken antipsychotic drug, 
Risperidone 2mg twice daily more than the weeks and 
PANSS score is about ≤ 75. In this preliminary study, 
we have found there was no statistically significant of 
the difference of HADS-A score based on gender. 
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This study was different from a study which 
conducted by Naidu et al., in South Africa, because it 
carried out in the acute phase of schizophrenia 
treatment that indicates there was an increase of SCI-
PANSS score, CDSS, HAM-A and S-SARS scores. 
To analysis, more variable is better than only 
to analysis HADS based on gender. That is the 
limitation of this study. If there is no statistically 
significant of HADS-A score until finishing this 
research, we can conclude that in the stabilisation 
phase of treatment, whereas the patient has got 
treatment, anxiety syndrome is not prominent 
anymore.  
Moreover, anxiety disorder usually comorbid 
with schizophrenia; it must be a concern for us. By 
measuring anxiety score to the schizophrenic patient 
gradually, it can prevent the occurrence of more 
severe anxiety disorders and can overcome them 
earlier.  
From this preliminary study, we found that 
there is no statistically significant HADS-A score from 
Batak male and female with schizophrenia. 
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